152. Going Out on a Limb - An Approach to Peripheral Arterial Disease

152. Going Out on a Limb - An Approach to Per...

Up next

Approach to Porphyria

Send us Fan MailIn this episode, we discuss an approach to porphyria. Written by Dr. Hannah Ramsay (Internal Medicine Resident). Reviewed by Dr. Karla Machlab (Hematology Fellow) and Dr. Zachary Liederman (Hematology Staff). Support the show 

An Approach to Anaphylaxis

Send us Fan MailIn this episode, we discuss an approach to the acute management of anaphylaxis. Written by Dr. Jen Zheng (Internal Medicine Resident). Reviewed by Dr. Raymond Mak, (Allergist and Clinical Immunologist) and Dr. Matthew Brooks, (General Internist).Support the show 

Recommended Episodes

Infective Endocarditis-Associated Stroke
EMplify by EB Medicine

Announcements: The interactive Clinical Pathways have launched and they are available for free! In this episode, Sam Ashoo, MD, and TR Eckler, MD, discuss the March 2023 Emergency Medicine Practice article on Emergency Department Management of Infective Endocarditis-Associated St ...  Show more

Prevention of Microvascular Complications in Diabetes: Where Do We Stand?
Keeping Current

Join Dr Peters for an update in approaches to managing microvascular complications. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/933885?src=mkm_podcast_addon_933885 

Episode 131: VTE Series-Approach to workup and initial management
The Fellow on Call: The Heme/Onc Podcast

This week, we kick off a new, highly-anticipated and highly-requested series, covering venous thromboembolism (VTE). In this first episode, we discuss how we make the initial diagnosis and how we approach in ...

  Show more

The 2 Minute Medicine® Podcast- Episode 35
The 2 Minute Medicine® Podcast

We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-c ...

  Show more